(Reuters) – Pfizer Inc on Tuesday raised its forecast for 2021 COVID-19 vaccine sales by more than 70% to $26 billion and said demand from…
Read More
Malaria vaccine ‘first to meet WHO efficacy target’
A malaria vaccine candidate tested on children in West Africa has shown an efficacy of around 77 percent, say scientists, hailing it as a breakthrough…
Read More
Guidance on diagnosis and management of cerebral venous sinus thrombosis after a COVID-19 vaccine
Last Friday, the Centers for Disease Control and Prevention (CDC) and the U.S. Food & Drug Administration (FDA) lifted the pause in administration of the…
Read More
Spain to Test Mixing COVID Vaccines After Restricting AZ Shot
MADRID (Reuters) – Spain will study the effects of mixing different coronavirus vaccines, government researchers said on Monday, responding to shifting guidelines on the safety…
Read More
Thailand gov’t negotiating to buy Pfizer coronavirus vaccine
Thai Prime Minister Prayuth Chan-ocha, under intense criticism for failing to secure adequate supplies of coronavirus vaccines, said Tuesday his government is negotiating to buy…
Read More
Germany expects vaccine deliveries to ramp up in 2nd quarter
Germany’s health minister on Monday welcomed the announcement by two pharmaeutical companies that they will deliver more coronavirus vaccines during the second quarter than previously…
Read More
Fauci sees decision on US resuming J&J vaccine by Friday
A decision on whether to end a US pause in vaccinations with the Johnson & Johnson COVID-19 shot is likely by Friday, top US pandemic…
Read More
Fauci expects Johnson & Johnson COVID-19 vaccine will 'get back on track' soon
CDC advisory panel delays vote while J&J vaccine info is collected FOX News correspondent Jonathan Serrie joins ‘Special Report’ with the details America’s leading infectious…
Read More
South Africa Suspends J&J Vaccine Rollout After US Pause
JOHANNESBURG (Reuters) – South Africa has suspended the rollout of Johnson & Johnson’s (J&J) COVID-19 vaccine, its health minister said on Tuesday, after U.S. federal…
Read More
France Extends Gap Between mRNA Vaccine Shots to Ramp-up Rollout
PARIS (Reuters) – France will lengthen the period between the first and second shots of mRNA anti-COVID vaccines to six weeks from four weeks as…
Read More